is communication may be deemed to be solicitation material in respect
of the proposed transaction between Thermage and Reliant. In connection
with the transaction, Thermage has filed a registration statement on Form
S-4 with the SEC containing a proxy statement/prospectus/ information
statement. The proxy statement/prospectus/information statement will be
mailed to the stockholders of Thermage and Reliant. Investors and security
holders of Thermage and Reliant are urged to read the proxy
statement/prospectus/information statement when it becomes available
because it will contain important information about Thermage, Reliant and
the proposed transaction. The proxy statement/prospectus/information
statement (when it becomes available), and any other documents filed by
Thermage with the SEC, may be obtained free of charge at the SEC's web site
at
http://www.sec.gov. In addition, investors and security holders may
obtain free copies of the documents filed with the SEC by Thermage by
contacting Thermage Investor Relations by e-mail at
IR@thermage.com or by
telephone at (510) 259-7117. Investors and security holders are urged to
read the proxy statement/prospectus/information statement and the other
relevant materials when they become available before making any voting or
investment decision with respect to the proposed transaction.
Thermage, Inc.
CONDENSED STATEMENTS OF OPERATIONS
(in thousands of dollars, except share and per share data)
(unaudited)
Three Months Ended Nine Months Ended
September 30, September 30,
2008 2007 2008 2007
Net revenue $13,020 $13,865 $47,132 $46,519
Cost of
'/>"/>
SOURCE Thermage, Inc. Copyright©2008 PR Newswire. All rights reserved | |
Page: 1 2 3 4 5 6 7 8 9 Related medicine news :1.
Thermage Discloses Preliminary 3Q 2008 Results for Thermage and Reliant2.
Thermage, Inc. to Present at the Maxim Group Growth Conference3.
Thermage Announces Second Quarter 2008 Financial Results4.
Thermage, Inc. to Present at the Fourth Annual Collins Stewart Growth Conference5.
Thermage and Reliant Technologies to Join Forces6.
Thermage, Inc. to Present at the Bank of America 2008 Healthcare Conference7.
Thermage, a Leading Aesthetic Medical Device Company, Announces First Time Exhibitor Status at ACOG Meeting8.
Thermage, Inc. Announces First Quarter 2008 Results Release Date and Conference Call9.
Thermage, Inc. Announces Initial Shipments of Cellulite Product10.
Thermage Announces Fourth Quarter and Full Year 2007 Financial Results11.
Thermage, Inc. Announces Fourth Quarter 2007 Results Release Date and Conference Call